Normal platelet activation profile in patients with peripheral arterial disease on aspirin

Thrombosis Research

Volumn 135, Issue 3, 2015, Pages 513-520

  Van Geffen, Johanna P ^a   Kleinegris, Marie Claire ^a   Verdoold, Remco ^a   Baaten, Constance C F M J ^a   Cosemans, Judith M E M ^a   Clemetson, Kenneth J ^b   Ten Cate, Hugo ^a   Roest, Mark ^c,d   De Laat, Bas ^d   Heemskerk, Johan W M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; COLLAGEN; GLYCOPROTEIN VI; INTEGRIN; THROMBIN RECEPTOR; ANTITHROMBOCYTIC AGENT;

AGED; ARTICLE; ASSAY; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; MALE; MICROARRAY ANALYSIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLATELET REACTIVITY; PRIORITY JOURNAL; STIMULATION; THROMBOCYTE ACTIVATION; BLOOD; COMPLICATION; DRUG EFFECTS; MIDDLE AGED; THROMBOCYTE; THROMBOSIS;

AGED; ASPIRIN; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; THROMBOSIS;

EID: 84925811747     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.12.029     Document Type: Article

References (47)

1. G.J. Hankey, P.E. Norman, and J.W. Eikelboom Medical treatment of peripheral arterial disease JAMA 295 2006 547 553
2. M. Sartori, E. Favaretto, C. Legnani, M. Cini, E. Conti, and A. Amato Thrombophilic risk factors and peripheral arterial disease severity Thromb Haemost 104 2010 71 77
3. C.M. Wahlgren, and P.K. Magnusson Genetic influences on peripheral arterial disease in a twin population Arterioscler Thromb Vasc Biol 31 2011 678 682
4. P.C. Bennett, S.H. Silverman, P.S. Gill, and G.Y. Lip Peripheral arterial disease and Virchow's triad Thromb Haemost 101 2009 1032 1040
5. U. Zeymer, K.G. Parhofer, D. Pittrow, C. Binz, M. Schwertfeger, and T. Limbourg Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort Clin Res Cardiol 98 2009 249 256
6. C.B. Reininger, J. Graf, A.J. Reininger, M. Spannagl, B. Steckmeier, and L. Schweiberer Increased platelet and coagulatory activity indicate ongoing thrombogenesis in peripheral arterial disease Thromb Res 82 1996 523 532
7. G.D. Lowe, A. Rumley, A.D. McMahon, I. Ford, D.S. O'Reilly, and C.J. Packard Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease Arterioscler Thromb Vasc Biol 24 2004 1529 1534
8. M.M. McDermott, and D.M. Lloyd-Jones The role of biomarkers and genetics in peripheral arterial disease J Am Coll Cardiol 54 2009 1228 1237
9. J.P. Cooke, and A.M. Wilson Biomarkers of peripheral arterial disease J Am Coll Cardiol 55 2010 2017 2023
10. M.C. Kleinegris, H. ten Cate, and A.J. ten Cate-Hoek D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease. A systematic review Thromb Haemost 110 2013 233 243
11. S.E. Musicant, L.M. Taylor Jr., D. Peters, R.A. Schuff, R. Urankar, and G.J. Landry Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease J Vasc Surg 43 2006 772 780
12. J. Zahavi, and M. Zahavi Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease Thromb Haemost 53 1985 105 109
13. K. Vanschoonbeek, M.A. Feijge, J.F. Keuren, H. Coenraad Hemker, J.J. Lodder, and K. Hamulyak Thrombin-induced hyperactivity of platelets of young stroke patients: involvement of thrombin receptors in the subject-dependent variability in Ca2 + signal generation Thromb Haemost 88 2002 931 937
14. P.A. Robless, D. Okonko, P. Lintott, A.O. Mansfield, D.P. Mikhailidis, and G.P. Stansby Increased platelet aggregation and activation in peripheral arterial disease Eur J Vasc Endovasc Surg 25 2003 16 22
15. K. Cassar, P. Bachoo, I. Ford, M. Greaves, and J. Brittenden Platelet activation is increased in peripheral arterial disease J Vasc Surg 38 2003 99 103
16. S.W. Galt, M.D. McDaniel, K.A. Ault, J. Mitchell, and J.L. Cronenwett Flow cytometric assessment of platelet function in patients with peripheral arterial occlusive disease J Vasc Surg 14 1991 747 755
17. K. Ouriel Peripheral arterial disease Lancet 358 2001 1257 1264
18. P. Poredos, M.K. Jezovnik, E. Kalodiki, G.M. Andreozzi, P.L. Antignani, and D. Clement Medical management of patients with peripheral arterial disease Int Angiol 2014
19. G. Lessiani, N. Vazzana, C. Cuccurullo, D. Di Michele, G. Laurora, and G. Sgro Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost Thromb Haemost 105 2011 321 328
20. A. Burdess, A.E. Michelsen, F. Brosstad, K.A. Fox, D.E. Newby, and A.F. Nimmo Platelet activation in patients with peripheral vascular disease: reproducibility and comparability of platelet markers Thromb Res 129 2012 50 55
21. A.D. Blann, K.T. Tan, M.H. Tayebjee, I. Davagnanam, M. Moss, and G.Y. Lip Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty Thromb Haemost 93 2005 578 583
22. M. Roest, T.C. van Holten, G.J. Fleurke, and J.A. Remijn Platelet activation test in unprocessed blood (Pac-t-UB) to monitor platelet concentrates and whole blood of thrombocytopenic patients Transfus Med Hemother 40 2013 117 125
23. A.H. Goodall, and J. Appleby Flow-cytometric analysis of platelet-membrane glycoprotein expression and platelet activation Methods Mol Biol 272 2004 225 253
24. P.E. van der Meijden, A.C. Bouman, M.A. Feijge, R. van Oerle, H.M. Spronk, and K. Hamulyak Platelet dysfunction in thrombosis patients treated with vitamin K antagonists and recurrent bleeding PLoS One 8 2013 e64112
25. Z.M. Ruggeri, and G.L. Mendolicchio Adhesion mechanisms in platelet function Circ Res 100 2007 1673 1685
26. F. Swieringa, M.J. Kuijpers, J.W. Heemskerk, and P.E. van der Meijden Targeting platelet receptor function in thrombus formation: the risk of bleeding Blood Rev 28 2014 9 21
27. D. Stegner, E.J. Haining, and B. Nieswandt Targeting glycoprotein VI and the immunoreceptor tyrosine-based activation motif signaling pathway Arterioscler Thromb Vasc Biol 34 2014 1615 1620
28. S.M. de Witt, F. Swieringa, R. Cavill, M.M. Lamers, R. van Kruchten, and T. Mastenbroek Identification of platelet function defects by multi-parameter assessment of thrombus formation Nat Commun 5 2014 4257
29. A.P. Mota, M.E. de Castro Santos, F. Lima e Silva, N.C. de Carvalho Schachnik, M. de Oliveira Sousa, and M. das Gracas Carvalho Hypercoagulability markers in patients with peripheral arterial disease: association to ankle-brachial index Angiology 60 2009 529 535
30. M.A. Allison, M.H. Criqui, R.L. McClelland, J.M. Scott, M.M. McDermott, and K. Liu The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA) J Am Coll Cardiol 48 2006 1190 1197
31. G.C. Leng, and F.G. Fowkes The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys J Clin Epidemiol 45 1992 1101 1109
32. S.M. de Witt, F. Swieringa, J.W. Heemskerk, and J.M. Cosemans Multi-parameter assessment of thrombus formation on microspotted arrays of thrombogenic surfaces Nat Protoc Exch 2014 [http://wwwnaturecom/protocolexchange/protocols/3309]
33. E. Westein, A.D. van der Meer, M.J. Kuijpers, J.P. Frimat, A. van den Berg, and J.W. Heemskerk Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner Proc Natl Acad Sci U S A 110 2013 1357 1362
34. J.W. Heemskerk, K.S. Sakariassen, J.J. Zwaginga, L.F. Brass, S.P. Jackson, and R.W. Farndale Collagen surfaces to measure thrombus formation under flow: possibilities for standardization J Thromb Haemost 9 2011 856 858
35. I.C. Munnix, K. Gilio, P.R. Siljander, N. Raynal, M.A. Feijge, and T.M. Hackeng Collagen-mimetic peptides mediate flow-dependent thrombus formation by high- or low-affinity binding of integrin alpha2beta1 and glycoprotein VI J Thromb Haemost 6 2008 2132 2142
36. R. Van Kruchten, J.M. Cosemans, and J.W. Heemskerk Measurement of whole blood thrombus formation using parallel-plate flow chambers - a practical guide Platelets 23 2012 229 242
37. E.R. van Bladel, R.E. Schutgens, K. Fischer, P.G. de Groot, and M. Roest Platelet degranulation and glycoprotein IIbIIIa opening are not related to bleeding phenotype in severe haemophilia A patients Thromb Haemost 111 2014 1022 1030
38. B.B. Dawood, J. Wilde, and S.P. Watson Reference curves for aggregation and ATP secretion to aid diagnose of platelet-based bleeding disorders: effect of inhibition of ADP and thromboxane A2 pathways Platelets 18 2007 329 345
39. I.C. Munnix, A. Strehl, M.J. Kuijpers, J.M. Auger, P.E. van der Meijden, and M.A. van Zandvoort The glycoprotein VI-phospholipase Cgamma2 signaling pathway controls thrombus formation induced by collagen and tissue factor in vitro and in vivo Arterioscler Thromb Vasc Biol 25 2005 2673 2678
40. J.S. Berger, M.J. Krantz, J.M. Kittelson, and W.R. Hiatt Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials JAMA 301 2009 1909 1919
41. G.R. Van de Walle, A. Schoolmeester, B.F. Iserbyt, J.M. Cosemans, J.W. Heemskerk, and M.F. Hoylaerts Activation of alphaIIbbeta3 is a sufficient but also an imperative prerequisite for activation of alpha2beta1 on platelets Blood 109 2007 595 602
42. C. Lecut, A. Schoolmeester, M.J. Kuijpers, J.L. Broers, M.A. van Zandvoort, and K. Vanhoorelbeke Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation Arterioscler Thromb Vasc Biol 24 2004 1727 1733
43. J.M. Cosemans, A. Angelillo-Scherrer, N.J. Mattheij, and J.W. Heemskerk The effects of arterial flow on platelet activation, thrombus growth, and stabilization Cardiovasc Res 99 2013 342 352
44. R. Li, and S.L. Diamond Detection of platelet sensitivity to inhibitors of COX-1, P2Y(1), and P2Y(1)(2) using a whole blood microfluidic flow assay Thromb Res 133 2014 203 210
45. K. Hosokawa, T. Ohnishi, H. Sameshima, N. Miura, T. Ito, and T. Koide Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions Thromb Haemost 109 2013 102 111
46. P.R. Siljander, I.C. Munnix, P.A. Smethurst, H. Deckmyn, T. Lindhout, and W.H. Ouwehand Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood Blood 103 2004 1333 1341
47. J.W. Heemskerk, N.J. Mattheij, and J.M. Cosemans Platelet-based coagulation: different populations, different functions J Thromb Haemost 11 2013 2 16